Nipro Vascular Innovations Americas, Inc.

Nipro Vascular Innovations Americas, Inc. is a medical device company specializing in intravascular imaging platforms for coronary and peripheral interventional cardiology. The company manufactures and distributes advanced catheter-based diagnostic systems that provide high-resolution structural imaging and plaque composition analysis to guide percutaneous coronary intervention (PCI) and peripheral vascular interventions. Primary product lines include Clarispro® HD-IVUS (intravascular ultrasound for vessel structure visualization), Dualpro® IVUS+ NIRS (dual-modality system combining intravascular ultrasound with near-infrared spectroscopy to identify lipid-core plaques and assess plaque vulnerability), and Makoto® Intravascular Imaging (integrated platform combining structural and compositional imaging for real-time treatment guidance). These technologies are designed to reduce major adverse cardiac events (MACE) and improve clinical outcomes in interventional procedures. The company serves interventional cardiologists, interventional radiologists, and vascular specialists in hospital catheterization laboratories and outpatient intervention centers. Nipro Vascular Innovations Americas represents the consolidation of formerly independent companies Infraredx and Avantec Vascular under the Nipro brand, leveraging combined expertise in optical coherence tomography (OCT), intravascular ultrasound (IVUS), and near-infrared spectroscopy (NIRS) technologies. Products are intended for use in coronary and peripheral vascular diagnostics and are subject to FDA regulation as Class II/Class III medical devices.